N3-substituted imidazopyridine c-Kit inhibitors
US7442709B2 · kind B2 · utility
1Cited by
21References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 16, 2004 |
| Grant date | Oct 28, 2008 |
| Priority date | — |
| Expiry date | Aug 16, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds represented by Formula (I):or a pharmaceutically acceptable salt or N-oxide thereof, are useful in the treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.